EvokAI Creative Labs Inc
XTSX:OKAI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EvokAI Creative Labs Inc
Net Issuance of Debt
EvokAI Creative Labs Inc
Net Issuance of Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
EvokAI Creative Labs Inc
XTSX:OKAI
|
Net Issuance of Debt
-CA$77.1k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Biotricity Inc
NASDAQ:BTCY
|
Net Issuance of Debt
$1m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-2%
|
|
|
C
|
CardioComm Solutions Inc
XTSX:EKG
|
Net Issuance of Debt
CA$398.1k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
298%
|
CAGR 10-Years
N/A
|
|
|
Avricore Health Inc
XTSX:AVCR
|
Net Issuance of Debt
CA$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diagnos Inc
XTSX:ADK
|
Net Issuance of Debt
-CA$954.2k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
N
|
NetraMark Holdings Inc
CNSX:AIAI
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
EvokAI Creative Labs Inc
Glance View
Evokai Creative Labs, Inc. engages in the development of transformational and innovative technologies for the modern healthcare sector. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2011-05-09. The firm is engaged in the development of transformational technologies for the modern health care sector. The company deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. The firm offers its AI algorithms across the whole health care system, from hospitals, private clinics, research institutions, pharmaceutical companies, contract research organizations to medical professionals, patients, and healthy individuals, aiming at preventing and early detecting any kind of disease and beyond, protecting the aging genome. Its divisions include EvokAI Simulators, EvokAI Sensors, EvokAI Neurotrainer and EvokAI Medical.
See Also
What is EvokAI Creative Labs Inc's Net Issuance of Debt?
Net Issuance of Debt
-77.1k
CAD
Based on the financial report for Dec 31, 2023, EvokAI Creative Labs Inc's Net Issuance of Debt amounts to -77.1k CAD.
